HHeadlines Read More BiomX Reports Second Quarter 2025 Financial Results and Provides Program UpdatesAugust 13, 2025 BiomX Inc Positive Phase 2 results for BX211 demonstrated >40% wound size reduction vs. placebo in diabetic foot…